215 related articles for article (PubMed ID: 17698705)
1. Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations.
Van Deerlin VM; Wood EM; Moore P; Yuan W; Forman MS; Clark CM; Neumann M; Kwong LK; Trojanowski JQ; Lee VM; Grossman M
Arch Neurol; 2007 Aug; 64(8):1148-53. PubMed ID: 17698705
[TBL] [Abstract][Full Text] [Related]
2. Distinct genetic forms of frontotemporal dementia.
Seelaar H; Kamphorst W; Rosso SM; Azmani A; Masdjedi R; de Koning I; Maat-Kievit JA; Anar B; Donker Kaat L; Breedveld GJ; Dooijes D; Rozemuller JM; Bronner IF; Rizzu P; van Swieten JC
Neurology; 2008 Oct; 71(16):1220-6. PubMed ID: 18703462
[TBL] [Abstract][Full Text] [Related]
3. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations.
Josephs KA; Ahmed Z; Katsuse O; Parisi JF; Boeve BF; Knopman DS; Petersen RC; Davies P; Duara R; Graff-Radford NR; Uitti RJ; Rademakers R; Adamson J; Baker M; Hutton ML; Dickson DW
J Neuropathol Exp Neurol; 2007 Feb; 66(2):142-51. PubMed ID: 17278999
[TBL] [Abstract][Full Text] [Related]
4. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.
Beck J; Rohrer JD; Campbell T; Isaacs A; Morrison KE; Goodall EF; Warrington EK; Stevens J; Revesz T; Holton J; Al-Sarraj S; King A; Scahill R; Warren JD; Fox NC; Rossor MN; Collinge J; Mead S
Brain; 2008 Mar; 131(Pt 3):706-20. PubMed ID: 18234697
[TBL] [Abstract][Full Text] [Related]
5. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.
Le Ber I; Camuzat A; Hannequin D; Pasquier F; Guedj E; Rovelet-Lecrux A; Hahn-Barma V; van der Zee J; Clot F; Bakchine S; Puel M; Ghanim M; Lacomblez L; Mikol J; Deramecourt V; Lejeune P; de la Sayette V; Belliard S; Vercelletto M; Meyrignac C; Van Broeckhoven C; Lambert JC; Verpillat P; Campion D; Habert MO; Dubois B; Brice A;
Brain; 2008 Mar; 131(Pt 3):732-46. PubMed ID: 18245784
[TBL] [Abstract][Full Text] [Related]
6. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.
van Swieten JC; Heutink P
Lancet Neurol; 2008 Oct; 7(10):965-74. PubMed ID: 18771956
[TBL] [Abstract][Full Text] [Related]
7. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin.
Mukherjee O; Pastor P; Cairns NJ; Chakraverty S; Kauwe JS; Shears S; Behrens MI; Budde J; Hinrichs AL; Norton J; Levitch D; Taylor-Reinwald L; Gitcho M; Tu PH; Tenenholz Grinberg L; Liscic RM; Armendariz J; Morris JC; Goate AM
Ann Neurol; 2006 Sep; 60(3):314-22. PubMed ID: 16983685
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia.
Mukherjee O; Wang J; Gitcho M; Chakraverty S; Taylor-Reinwald L; Shears S; Kauwe JS; Norton J; Levitch D; Bigio EH; Hatanpaa KJ; White CL; Morris JC; Cairns NJ; Goate A
Hum Mutat; 2008 Apr; 29(4):512-21. PubMed ID: 18183624
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.
Rademakers R; Baker M; Gass J; Adamson J; Huey ED; Momeni P; Spina S; Coppola G; Karydas AM; Stewart H; Johnson N; Hsiung GY; Kelley B; Kuntz K; Steinbart E; Wood EM; Yu CE; Josephs K; Sorenson E; Womack KB; Weintraub S; Pickering-Brown SM; Schofield PR; Brooks WS; Van Deerlin VM; Snowden J; Clark CM; Kertesz A; Boylan K; Ghetti B; Neary D; Schellenberg GD; Beach TG; Mesulam M; Mann D; Grafman J; Mackenzie IR; Feldman H; Bird T; Petersen R; Knopman D; Boeve B; Geschwind DH; Miller B; Wszolek Z; Lippa C; Bigio EH; Dickson D; Graff-Radford N; Hutton M
Lancet Neurol; 2007 Oct; 6(10):857-68. PubMed ID: 17826340
[TBL] [Abstract][Full Text] [Related]
10. Sporadic and familial dementia with ubiquitin-positive tau-negative inclusions: clinical features of one histopathological abnormality underlying frontotemporal lobar degeneration.
Godbolt AK; Josephs KA; Revesz T; Warrington EK; Lantos P; King A; Fox NC; Al Sarraj S; Holton J; Cipolotti L; Khan MN; Rossor MN
Arch Neurol; 2005 Jul; 62(7):1097-101. PubMed ID: 16009765
[TBL] [Abstract][Full Text] [Related]
11. Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation.
Behrens MI; Mukherjee O; Tu PH; Liscic RM; Grinberg LT; Carter D; Paulsmeyer K; Taylor-Reinwald L; Gitcho M; Norton JB; Chakraverty S; Goate AM; Morris JC; Cairns NJ
Alzheimer Dis Assoc Disord; 2007; 21(1):1-7. PubMed ID: 17334266
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic correlation in PGRN mutations.
Davion S; Johnson N; Weintraub S; Mesulam MM; Engberg A; Mishra M; Baker M; Adamson J; Hutton M; Rademakers R; Bigio EH
Neurology; 2007 Sep; 69(11):1113-21. PubMed ID: 17522386
[TBL] [Abstract][Full Text] [Related]
13. Plasma progranulin levels in cortical dementia phenotypes with asymmetric perisylvian atrophy.
Gómez-Tortosa E; Guerrero-López R; Gil-Neciga E; Franco E; del Ser T; Jiménez Escrig A; Pérez-Pérez J; Sainz MJ
Eur J Neurol; 2013 Sep; 20(9):1319-24. PubMed ID: 23724906
[TBL] [Abstract][Full Text] [Related]
14. Clinical, neuropathological, and genetic characteristics of the novel IVS9+1delG GRN mutation in a patient with frontotemporal dementia.
Taipa R; Tuna A; Damásio J; Pinto PS; Cavaco S; Pereira S; Milterberger-Miltenyi G; Galimberti D; Melo-Pires M
J Alzheimers Dis; 2012; 30(1):83-90. PubMed ID: 22366770
[TBL] [Abstract][Full Text] [Related]
15. Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations.
Whitwell JL; Jack CR; Baker M; Rademakers R; Adamson J; Boeve BF; Knopman DS; Parisi JF; Petersen RC; Dickson DW; Hutton ML; Josephs KA
Arch Neurol; 2007 Mar; 64(3):371-6. PubMed ID: 17353379
[TBL] [Abstract][Full Text] [Related]
16. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia.
Snowden JS; Pickering-Brown SM; Mackenzie IR; Richardson AM; Varma A; Neary D; Mann DM
Brain; 2006 Nov; 129(Pt 11):3091-102. PubMed ID: 17003069
[TBL] [Abstract][Full Text] [Related]
17. A mutation in the 5'-UTR of GRN gene associated with frontotemporal lobar degeneration: phenotypic variability and possible pathogenetic mechanisms.
Puoti G; Lerza MC; Ferretti MG; Bugiani O; Tagliavini F; Rossi G
J Alzheimers Dis; 2014; 42(3):939-47. PubMed ID: 25024321
[TBL] [Abstract][Full Text] [Related]
18. A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review.
Hosaka T; Ishii K; Miura T; Mezaki N; Kasuga K; Ikeuchi T; Tamaoka A
BMC Neurol; 2017 Sep; 17(1):182. PubMed ID: 28915852
[TBL] [Abstract][Full Text] [Related]
19. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
[TBL] [Abstract][Full Text] [Related]
20. Granulin mutations associated with frontotemporal lobar degeneration and related disorders: an update.
Gijselinck I; Van Broeckhoven C; Cruts M
Hum Mutat; 2008 Dec; 29(12):1373-86. PubMed ID: 18543312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]